Core Viewpoint - The Chinese pharmaceutical manufacturing industry is experiencing significant growth in export value, with a notable increase in both monthly and cumulative figures for 2025 [1][2]. Group 1: Industry Overview - The export value of the pharmaceutical manufacturing industry in China reached 19.21 billion yuan in July 2025, marking a year-on-year growth of 12.6% [1]. - From January to July 2025, the cumulative export value of the pharmaceutical manufacturing industry was 134.31 billion yuan, reflecting a cumulative year-on-year growth of 11.1% [1]. Group 2: Companies Mentioned - Listed companies in the pharmaceutical sector include: Guoyao Modern (600420), Kunming Pharmaceutical Group (600422), Pian Zai Huang (600436), Qianjin Pharmaceutical (600479), Tianyao Pharmaceutical (600488), Guoyao Shares (600511), Lianhuan Pharmaceutical (600513), Hefei China (603122), Kanghui Pharmaceutical (603139), Shapu Aisi (603168), Aoxiang Pharmaceutical (603229), and Daclin (603233) [1]. Group 3: Research Report - The insights are derived from the "2025-2031 China Pharmaceutical Manufacturing Industry Market Development Trends and Prospects Strategic Research Report" published by Zhiyan Consulting [1]. - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in in-depth industry research reports and providing comprehensive industry solutions [2].
2025年1-7月全国医药制造业出口货值为1343.1亿元，累计增长11.1%
Chan Ye Xin Xi Wang·2025-08-29 05:03